Advantage Therapeutics
Manufacturing · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
215 N New River Dr E Ph 4200, Fort Laude...Phone Number
(630) 886-7345Revenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Advantage Therapeutics
Advantage Therapeutics is dedicated to developing a novel immunotherapy aimed at treating early Alzheimer's Disease. With a focus on advancing breakthrough therapies, the company is currently preparing for clinical trials in Europe and the US. Their lead product candidate, AD04, has shown promise in modifying disease progression, highlighting their commitment to transforming the treatment landscape for neurodegenerative conditions. The firm strives to combine cutting-edge scientific expertise with a passion for developing life-enhancing medical solutions for patients worldwide.Explore more
Advantage Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Advantage Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if Advantage Therapeutics is spiking on competitors!
Click to see if Advantage Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when Advantage Therapeutics launches new products
Advantage Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Advantage Therapeutics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Advantage Therapeutics
Check if Advantage Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Advantage Therapeutics recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Advantage Therapeutics
Compare insights from companies similar to Advantage Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Advantage Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Advantage Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Advantage Therapeutics.
Advantage Therapeutics financials insights
Gather financial insights about Advantage Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Private Equity
$13.7M
Advantage Therapeutics News & Media
UPDATE -- ADvantage Therapeutics Awarded $2.5 Million NIH SBIR Grant to Advance Alzheimer’s Drug Candidate AD04® Toward the Clinic
ADvantage Therapeutics Awarded $2.5 Million NIH SBIR Grant to Advance Alzheimer’s Drug Candidate AD04® Toward the ClinicADvantage Therapeutics Awarded $2.5 milion NIH SBIR Grant to Advance Alzheimer’s Drug Candidate AD04® Toward the Clinic
ADvantage Therapeutics Awarded $2.5 milion NIH SBIR Grant to Advance Alzheimer’s Drug Candidate AD04® Toward the ClinicADvantage Therapeutics Awarded $2.5 Million NIH SBIR Grant to Advance Alzheimer’s Drug Candidate AD04® Toward the Clinic
ADvantage Therapeutics Awarded $2.5 milion NIH SBIR Grant to Advance Alzheimer’s Drug Candidate AD04® Toward the ClinicKlothea Bio Collaborates with Healthy Longevity Clinic, a Top 40 Semifinalist in $101 million XPRIZE Healthspan Competition
MIAMI, May 15, 2025 (GLOBE NEWSWIRE) -- Klothea Bio Inc., a biotechnology company pioneering mRNA-based therapies to upregulate the anti-aging protein Klotho, today announced its ongoing collaboration with Healthy Longevity Clinic (HLC), which was recognized yesterday as a Top 40 Milestone 1 Semifinalist Team in the global XPRIZE Healthspan competition.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Advantage Therapeutics
Sign Up For FreeTo access detailed company insights
Advantage Therapeutics is dedicated to developing a novel immunotherapy aimed at treating early Alzheimer's Disease. With a focus on advancing breakthrough therapies, the company is currently preparing for clinical trials in Europe and the US. Their lead product candidate, AD04, has shown promise in modifying disease progression, highlighting their... Read More
